
KakaoPay, Toss Pay Pull Payment Services From Megabox as Court Freeze Locks Out Refunds
KakaoPay and Toss Pay pull payment gateway services from Megabox after Seoul Bankruptcy Court freezes JoongAng Group assets. Megabox carries 2,212% debt-to-equity ratio after 6 consecutive loss years.
- 02
Samsung's System LSI Guides to Annual Loss Despite Record Q1 Revenue as SoC Drag Persists
The head of Samsung Electronics' (005930
- 03
Intel Hires Former SK Hynix CEO Seok-Hee Lee to Run Its Advanced Packaging Push
Intel named former SK Hynix president Seok-Hee Lee as EVP of Intel Foundry, putting the Korean memory veteran in charge of advanced packaging as Intel chases profitable foundry revenue.
- 04
Hanmi Pharma (128940.KS) Q1 2026: R&D at 16.6% Narrows Operating Profit 9%
Hanmi Pharmaceutical Q1 2026: Revenue flat at ₩392.9B (+0.5%), operating profit -9.1% to ₩53.6B as R&D hit 16.6% of sales. Net income rose 14.4% to ₩51.1B. Beijing Hanmi's 22% margin cushions results.
- 05
Kia to Retire Granbird After 60 Years as Chinese EV Buses and Emissions Rules Squeeze Korea's Last Diesel Coach Maker
Kia will discontinue its Granbird large bus within 1-2 years, ending a 60-year legacy as Chinese EV buses and emissions rules make the diesel coach unprofitable.
- 06
OCI Holdings (010060.KS) Q1 2026: Operating Profit Collapses 78% on ₩26.6B TerraSus Maintenance Loss
- 07
IMM PE Seals ₩1.11 Trillion Deal to Take 80% of CGBio, Betting on USD 1.6 Billion in U.S. Medical Device Sales
- 08
South Korea Jumps to 21st in IMD World Competitiveness, Second-Highest Ever as Business Efficiency Surges 10 Spots
South Korea climbed six spots to 21st among 70 economies in the 2026 IMD World Competitiveness Yearbook, its second-highest result ever, driven by a 10-place surge in business efficiency and a rise to 15th in infrastructure.
- 09
LG Chem Partners with UK's LabGenius to Halve Cancer Antibody Discovery Timeline, Eyes Triple-Digit Milestones
LG Chem and UK-based LabGenius Therapeutics have signed a multi-year collaboration to develop AI-designed cancer antibodies using the EVA platform, with potential triple-digit million USD milestones.
- 10
POSCO International Seals ₩1.3 Trillion Indonesia Palm Bet With PT.PAR Launch, Targets Double Profit
POSCO International formally launched PT Prime Agri Resources in Jakarta on June 18, completing its palm oil value chain across 154,000 hectares in Indonesia and targeting double operating profit in 2026.
- 11
NC (036570.KS) Q1 2026: Aion 2 Ignites 22x Profit Jump to ₩113B
- 12
Korean Banks' JoongAng Group Exposure Tops ₩800 Billion as Receivership Tests Record Earnings
Five JoongAng Group units, including JTBC, sought court rehabilitation after a ₩700 billion sports-broadcast-rights bet went wrong. Hana Bank holds the largest exposure at ₩307 billion; analysts project limited provisioning impact on Korean lenders.
- 13
U.S. Poised to Scrap Biosimilar’s ‘Interchangeable’ Hurdle — Celltrion and Samsung Bioepis Stand to Gain Most
The bipartisan Biosimilar Red Tape Elimination Act (S.1954) and parallel FDA guidance would cut Korean drug makers’ development costs 70–90% and shorten timelines by up to four years.
- 14
Gaon Cable's U.S. Busduct Backlog Tops ₩5 Trillion as AI Data Center Deals Drive 2026 Orders to Double
LS Cable subsidiary Gaon Cable has amassed ₩5 trillion in U.S. AI data center busduct contracts via LSCUS, with 2026 orders set to double to ₩200 billion ($131M) as gen-AI firms join its customer base.
LineVest Daily
Get this wrap in your inbox every morning.
One email before the U.S. open — the earnings, filings, and guidance changes that matter, in plain English. Free.
Subscribe free